Genoscreen is a leading European commercial service provider in genomics and bioinformatics, as well as a developer and producer of proprietary kits for quality controlled bacterial genotyping. The company employs over 25 people including technicians, engineers, PhDs and senior scientists from the academic world as permanent consultants. Founded in 2001 and based in Lille (France), the company serves industrial, academic and hospital-based customers from over 30 countries over the 5 continents, including world-class or reference institutions such as the US CDC, NIH, RIVM and Paris hospital organisation (APHP).
Development of new sample preparation and analysis processes for NGS and novel NGS-based kits for clinical bacteriology/human pathogens analysis, whole genome sequencing of MTBC, MRSA and CAMPY strains, genome sequence analysis (esp. for MTBC), co-development of specific bio-informatics modules.
- Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease. Mol Psychiatry 2009 14 (11) : 1004--1016. [pmid]
- Representativeness of microsatellite distributions in genomes, as revealed by 454 GS-FLX titanium pyrosequencing. BMC Genomics 2010 11 : 560. [pmid]
- Origin, spread and demography of the Mycobacterium tuberculosis complex. PLoS Pathog 2008 4 (9) : e1000160. [pmid]